Table 1.

IPOE cases demographic and clinical data

Topical antibiotic	Gender	Age	General background	Ophthalmic background	Surgery	IPOE	Vitreous Culture	Final VA
Azithromycin	Male	85	DMII- OAD Dyslipidaemia	Pseudoexfoliation Glaucoma-prostaglandin treatment Myosis Pre-VA RE: 0.5	Expert surgeon IFIS 23 minutes surgery	8 days’ post-surgery IV AB + Topical reinforced eye drops + posterior vitrectomy	Coagulase negative Staphylococcus	0.5
Azithromycin	Male	71	Alcoholic liver disease, smoking, epilepsy, barbiturate intake	Mature cataract +++ Pre VA LE: 0.05	Novel surgeon 25 minutes surgery	7 days’ post-surgery IV AB + Topical reinforced eye drops + posterior vitrectomy	Negative	0.6
Ciprofloxacin	Female	90	Alzheimer Depression Arterial hypertension Obesity	Pseudoexfoliation Phacodonesis Pre VA LE: CF	Expert surgeon Stretching 28 minutes surgery	14 days’ post-surgery IV AB + Topical reinforced eye drops + posterior vitrectomy	Negative	HM
Ciprofloxacin	Male	73		Glaucoma Myopia Pre VA RE: 0.4	Novel surgeon Zonular dialysis Phenylephrine Iris hooks Anterior vitrectomy 31 minutes surgery	2 days’ post-surgery IV AB + Topical reinforced eye drops + posterior vitrectomy	Negative	0.8

IPOE: infectious postoperative endophthalmitis, DMII: Mellitus Diabetes type II, OAD: oral antidiabetics, Pre VA: previous Visual Acuity, RE: Right Eye, LE: Left Eye, IV AB: Intravitreal Antibiotics.